Pittayanon R, Lau JT, Leontiadis GI, et al
It is important to note that retatrutide is not yet authorised for use in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA), nor approved by the European Medicines Agency (EMA)
H., Qin, J., and Wu, X
Duration Comparison Across Receptor Agonists Key Takeaway On Retatrutides Half-Life Retatrutide maintains an extended half-life ranging from approximately 6 to 8 days, positioning it as a strong contender among modern metabolic therapies
IntechOpen, London Careri M, Furlattini L, Mangia A, Musci M, Anklam E, Theobald A, Von Holst C (2001) Supercritical fluid extraction for liquid chromatographic determination of carotenoids in Spirulina pacifica algae: a chemometric approach
Scientific sources Pooyandjoo M et al